|
|
|
|
|
Legal status
Patent in force
| (51) | INT.CL. | C07D 487/04 | (2006.01) |
| A61K 31/55 | (2006.01) | ||
| A61P 35/00 | (2006.01) |
| (11) | Number of the document | 2497772 |
| (13) | Kind of document | T |
| (96) | European patent application number | 12153131.3 |
| Date of filing the European patent application | 2007-11-14 | |
| (97) | Date of publication of the European application | 2012-09-12 |
| (45) | Date of publication and mention of the grant of the patent | 2014-10-29 |
| (46) | Date of publication of the claims translation | 2015-02-25 |
| (30) | Number | Date | Country code |
| 859340 P | 2006-11-16 | US |
| (72) |
Claiborne, Christopher F., US
Sells, Todd B., US
Stroud, Stephen G., US
|
| (73) |
Millennium Pharmaceuticals, Inc.,
40 Landsdowne Street, Cambridge, MA 02139,
US
|
| (74) |
Reda ŽABOLIENĖ,
METIDA, Verslo centras "VERTAS", Gynėjų g. 16, LT-01109 Vilnius,
LT
|
| (54) | Junginys, skirtas mitozinės progresijos slopinimui |
| Compound for inhibiting mitotic progression |
| Payment date | Validity (years) | Amount | |
| 2024-10-22 | 18 | 347.00 EUR |
| 2025-11-14 |